Looking at Compass Inc stock right now? You're probably wondering if this tech-enabled real estate giant is worth your attention. The short answer: Compass has posted record-breaking growth in 2025, with Q2…
Are you thinking about the right stocks to watch in India’s vibrant entertainment sector? If you’re eyeing long-term opportunities in India’s growing consumer markets, it will definitely catch your attention. Today, let’s…
EasyJet shows strong recovery potential in 2025. Moreover, recent earnings jumped 40% while passenger numbers grow steadily. Additionally, analysts predict 33% upside with price targets around 643p. Furthermore, the package…
LVMH is showing signs of a real recovery in 2025, as third-quarter organic sales returned to growth, selective retailing outperformed on the back of Sephora, and Asia ex-Japan improved, while…
BAC looks well-positioned for 2025. Earnings re-accelerated on strong investment banking activity, record net interest income, and disciplined costs. Moreover, analysts now see mid-teens upside over 12 months while credit…
DELTA Air Lines is crushing it in 2025. The airline stock delivered a massive 75.1% return this year. Moreover, it's trading at just 8.47 times earnings. This makes it one of…
Garden Reach Shipbuilders & Engineers (GRSE) shows remarkable financial strength. The company posted 48% profit growth in FY25. Revenue surged to ₹5,076 crores from ₹3,593 crores. Strong order book of…
AstraZeneca (AZN) is a large-cap, research-driven pharma leader with broad growth across oncology, cardiovascular–renal–metabolism, and respiratory–immunology, supported by rising U.S. focus, robust trial wins, and steady dividend credentials. Therefore, if…
If you are looking for a simple, no-nonsense view on MSTR, here it is: the stock is a leveraged proxy on Bitcoin with a real, but smaller, enterprise analytics business…
UnitedHealth Group (UNH) trades at compelling value levels after falling 46% year-to-date. However, Warren Buffett's recent $1.6 billion investment signals strong confidence in recovery prospects. The healthcare giant posted $400+…